Smile Digital Health Celebrates Dr. Shane McNamee's Recent Achievement

TORONTO - December 14, 2022 - (Newswire.com)

Smile Digital Health, a leading health data fabric and exchange platform, is proud to announce that Dr. Shane McNamee, Senior Vice President, Strategic Growth, Smile Digital Health, has been named as a 2023 FedHealthIT100 Award Winner. 

This distinguished award honors 100 individuals recognized for driving change and advancement in the Federal Health Information Technology and Consulting Market.

Dr. McNamee has more than 15 years of experience overseeing the development and implementation of interoperability tools on various healthcare and technology teams, including large complex US Public Sector and commercial sector healthcare organizations. 

Prior to joining Smile Digital Health, Dr. McNamee served in the Department of Veterans Affairs, spending years supporting the physical and psychological issues of severely combat-wounded and combat-exposed veterans. He also led VA and DoD data interoperability success in the Joint Legacy Viewer, helping to connect patient information across the federal landscape and was responsible for Fed Health IT systems integration at Peraton as CMIO. 

This is not the first time Dr. McNamee has been recognized. In 2022, he was also a recipient of this prestigious award, showing that he continues to push towards digital transformation in the healthcare industry. He raises awareness in the community through informative articles, discussions and speaking engagements.

In the past year at Smile Digital Health, Dr. McNamee helped establish the company's global market presence by powering product strategy, applied data to drive healthcare metrics, accelerated sales through business development, and built partnerships, alliances and distribution channels.

Along with these achievements, Dr. McNamee serves as the Executive Director for OMG® sponsored BPM+ Health Community and is a board member in IHE USA.

"We are beyond proud of our team's thought leadership. This award is a recognition of Shane's recent achievements and showcases those values that we, as an organization, strive towards," said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. 

FedHealthIT is a trusted content provider, connecting government and industry through their FedHealthIT magazine and website. 

"It is inspiring to see this year's list of winners, selected by a panel of current and former government and industry leaders from across the Federal Health IT sector. The work they have contributed to the industry is immense. We look forward to seeing how these efforts impact future transformations in the field," said Susan Sharer, Chief Executive Officer, FedHealthIT. 

The recipients were honored at the 7th Annual FedHealthIT100 Awards and Holiday Celebration on Wednesday, Dec. 7. The conference brought together senior healthcare executives from across the Federal Government and industry to focus on The Year Ahead, including the initiatives and programs that will be driving Federal Health IT in 2023.

About the FedHealthIT100

The FedHealthIT100 is an annual award honoring individuals who are making an impact, going above and beyond, driving innovation and positive outcomes, challenging conventional wisdom, and giving back to the larger HealthIT community. For further information, visit https://www.fedhealthit.com

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, health data fabric and exchange platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate, and meaningfully share health information to power digital transformation. We prepare healthcare providers, payers, researchers, and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. 

We help healthcare organizations confidently #ChooseOpenStandards with the goal of #BetterGlobalHealth. For more information, visit SmileDigitalHealth.com.

Contact Information:
Victoria Valladolid
Acting Director of Marketing
[email protected]
(877) 537-3343 x 728


Press Release Service by Newswire.com

Original Source: Shane McNamee of Smile Digital Health Named 2023 FedHealthIT100 Award Recipient

DES PLAINES, Ill. - December 14, 2022 - (Newswire.com)

CIMSS has acquired RxCompli, which enables them to offer a new technology platform to physicians that ensures their patients take the right medication at the right time. This is especially important because 50% of patients do not take medications as prescribed, resulting in $100 billion of unnecessary spending and 125,000 lives lost each year, according to Duke Health. Therefore, this acquisition will help prolong lives and lower costs for the patient.

"With the acquisition of RxCompli, we can offer easily deployable technology to physicians, like the app and cloud integration, so they can be sure that their patients are taking the right medication at the right time," says Dr. Paramjit "Romi" Chopra, MD and CEO of CIMSS. "Each physician and physician group we work with is at the center of our universe, and we believe in supporting them from beginning to end. By acquiring RxCompli, we can provide them with more support than ever before."

"We are very excited to see the impact our technology will have," says Sreenivasan Narayanan, CEO of RxCompli. "Dr. Chopra is an amazing physician and executive, so I have no doubt that he will take CIMSS to the next level with the help of our technology."

• RxCompli sensors stick on all kinds of containers (Pill Bottle, Pill Box, Inhaler, Injectables)
• The sensor sends out smart reminders using a combination of LED and buzzer
• The sensor automatically records medication intakes
• It flags overuse and underuse of medications
• It keeps a tab on the medication adherence and alerts for timely refills
• Once programmed, the sensor works independently of smart phones with a battery life of nine months

About CIMSS: Since its inception in 2011, CIMSS has remained a physician-owned and directed organization with aims to improve patient outcomes for their clients and reduce unnecessary health care costs. With headquarters in Chicago, CIMSS accomplishes its goals by providing the following healthcare management solutions: strategic planning and execution; EHR management; revenue cycle management (RCM); temporary and full-time staffing; marketing and lead generation services; CRM solutions; healthcare data management; and more.

About RxCompli: RxCompli is a personalized caregiver that alerts patients to take their medications as prescribed. Patients take the right medication and at the right time with the help of our sensors, SMART app, and reporting. 

To learn more about RxCompli, click here. To learn more about CIMSS, click here.

For all press inquiries, please contact Brian Kuntz at [email protected].

Contact Information:
Brian Kuntz
Comprehensive Integrated Management Systems and Solutions (CIMSS)
[email protected]
(847) 464-8480


Press Release Service by Newswire.com

Original Source: CIMSS Acquires RxCompli to Improve Patient Care and Quality of Life While Extending and Saving Patients Life

New Integration Delivers 52% Cost Savings and 88% Time Savings in Computational Execution with GPU-accelerated Industry-Standard Tools

DALLAS - December 14, 2022 - (Newswire.com)

Form Bio, the breakthrough computational life sciences platform, today announced the integration of the NVIDIA Clara Parabricks suite of genomic analysis tools with Form Bio's genomic analysis workflows. The integrated solution, provided by Form Bio, enables scientists, bioinformaticians, and other life science professionals to execute genomic workflows with acceleration fueled by GPU parallelization and deep learning AI tools. 

A recent comparison case demonstrates the high-performance combination of Form Bio's workflow execution engine and Parabricks. Specifically, in bringing the two solutions together, Form Bio measured a 52% reduction in overall cost and an 88% reduction in time to execute whole genome sequence analysis when compared with open-source tools—demonstrating dramatic improvements in overall computational efficiency.

"While Form Bio provides a best-in-class computational platform for the scientific community, we knew that Parabricks' GPU-optimized framework had the potential to reduce both the time and cost of analysis," said Brandi Cantarel, Ph.D., director of bioinformatics for Form Bio. "We're very pleased to see just how significant those time and cost savings can actually be in practice," she added.

The integrated solution is provided by Form Bio, whose platform includes a full suite of computational capabilities such as data management, workflow execution, data visualization, and collaboration—all within one cohesive "operating system" for computational life sciences. The integrated solution is generally available to biotech and pharmaceutical companies as well as academic institutions.

"Now more than ever, finding the best ways to get the most out of finite resources is critical in both the business of science as well as in academic research," said George Vacek, Global Head of Genomics Alliances at NVIDIA. "By collaborating with leading platforms like Form Bio to deliver dramatic computational time and cost savings, we empower scientists to efficiently accelerate their discoveries."

NVIDIA Parabricks GPU-accelerated workflows provide researchers with faster turnaround times and lower costs for a wide range of genomic data analyses. The solution can be utilized on prem, in the cloud, or via partner apps and solutions such as Form Bio.

To read the full case report, click here.

To request a demo of the joint solution, click here.

For more information on Clara Parabricks, click here, or to download, click here.
 

About Form Bio

Form Bio is a new, cutting-edge research and discovery platform for individuals and enterprises in life sciences. With an accessible, comprehensive, and collaborative platform, Form Bio empowers scientists to efficiently and effectively harness the proliferation of data and computing power that has transformed the science of discovery. Form offers end-to-end integration of the discovery process with intuitive and easy-to-use software applications, combined with an open and adaptable collaborative environment. For more information on Form Bio, visit www.formbio.com

Contact Information:
Maggie Whitney
Senior Public Relations Executive
[email protected]
2039571502

Alison Guzzio
Public Relations Director
[email protected]
4844593243


Press Release Service by Newswire.com

Original Source: Form Bio Brings Accelerated Genomic Analysis to Bioinformatics with NVIDIA Clara Parabricks

Award-winning company expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center.

HAUPPAUGE, N.Y. - December 14, 2022 - (Newswire.com)

Minicarm.com a privately held medical device award-winning company, expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center. Mini C-Arms are used for fluoroscopic imaging of the extremities in orthopedic surgery and digital diagnostic imaging. "This new refurbishment center was created to help improve our customers' experience, and it creates a more efficient work environment for our team," said VP of Minicarm.com, Joshua Bacon. 

This new refurbishment center will feature an in-house sanding booth and paint booth. This reflects minicarm.com's commitment to delivering only the highest quality refurbished Mini C-Arms across the globe. This investment will allow the team to improve quality control and be able to ship units same day to customers in need. 

About Minicarm.com

Minicarm.com is the leader in refurbished Mini C-Arm fluoroscopy sales, service & rentals. Mini C Arm LLC takes Mini C-Arm machines manufactured by Hologic, OEC, and Orthoscan, and remanufactures them so they look and operate once more as new. They are then sold, or rented out to clinics, hospitals, surgery centers and Doctors' offices all over the USA & the world. Christopher Bacon, President of Minicarm.com, is the technical founder of Orthoscan, one of the main Mini C-Arm manufacturers.

Contact:

[email protected]

Contact Information:
Joshua Bacon
[email protected]


Press Release Service by Newswire.com

Original Source: Minicarm.com Expands Their Operations With Their New Mini C-Arm Refurbishment Center

Two-day virtual training session will give participants the skills to identify and address ethical challenges

MALVERN, Pa. - December 14, 2022 - (Newswire.com)

The Center for Professional Innovation and Education (CfPIE), a global leader in life sciences training, has announced a new two-day virtual course addressing responsible, ethical conduct in research. Ethics in Research — Values for Responsible Conduct of Research will provide participants with the necessary concepts and vocabulary to engage with ethical challenges along with the skills to identify and address moral dilemmas. 

Hosted by Professor of Philosophy and Health Care Ethics at MCPHS University Ken Richman, Ph.D., the course is founded on and guided by three core ideas: 

• Ethics is part of our jobs and lives, and the need to apply ethical thinking is not a sign that something has gone wrong.
• Science is a profession, and scientific research comes with its own distinct set of standards.
• A researcher with the skills and confidence to discuss ethical challenges at work can lower their company's ethical liability risk. 

"Given the ever-evolving complexity concerning Ethics in Research, CfPIE is excited to offer our first course devoted to this topic and presented by one of the most respected experts on the subject," explains Mark Mazzie, CfPIE founder and CEO. "Kenneth Richman, Ph.D., combines philosophical concepts and real-world, practical examples to equip participants with everything they need to apply moral reasoning in both their personal and professional lives." 

Ethics in Research - Values for Responsible Conduct of Research will be hosted online from 9:00 a.m. to 5:00 p.m. CST on Jan. 30 and 31. Participants can register now here.

About CfPIE

The Center for Professional Innovation and Education (CfPIE) is the global leader in life sciences training, providing specialized courses for pharma/biotech, medical device, and skin/cosmetics topics. Classroom and custom on-site formats and certification programs help improve personal skills, maintain regulatory compliance, and advance careers. Small class sizes and industry-active course directors promote a dynamic learning environment with excellent student-to-teacher interaction. More information: http://www.cfpie.com

Contact Information:
Mark Mazzie
CfPIE founder and CEO
[email protected]


Press Release Service by Newswire.com

Original Source: CfPIE Introduces New Course on Ethics in Medical Research

LAKE SAINT LOUIS, Mo. - December 13, 2022 - (Newswire.com)

As a reflection of its promise to deliver a long-term commitment to social responsibility to its clients, members, and community stakeholders, MTM has officially released its formal ESG Charter. The comprehensive charter supports MTM's ongoing efforts related to environmental stewardship, social responsibility, and corporate governance (ESG).

Through the ESG Charter, MTM clearly defines the organization's ESG priorities, objectives, and strategies, broken down into three primary categories: 

• A promise to mitigate the impact of climate change through sustainable transportation solutions
• A promise to empower and give back to communities through diversity, social responsibility, charitable giving, and employee development
• A promise to sustain a culture of excellence and reliability through steadfast governance practices

"At MTM, ESG practices are woven into the thread of the company's existence," said MTM's President and CEO Alaina Macia. "Without our founders' vision for a better tomorrow where no one has to wonder how they will access healthcare, the MTM we know today wouldn't exist. Over the past 25-plus years, we've thought carefully about our approach to ESG. We understand that ESG commitments create value by fostering innovation, building trust, increasing efficiencies, keeping employees engaged, and improving overall performance. We always consider our impact and strive to create a better world for all—one trip at a time—as we keep our company strong for generations to come." 

Also within the charter, MTM sets forth a baseline for ESG efforts nationwide. Highlights include:

• A commitment to workplace diversity, with 51% of employees identifying as BIPOC in 2022
• A female-led team, with 61% of teammates and 54% of leaders identifying as female in 2022
• Efforts to drive the transportation industry toward a more sustainable future, including reducing offices and encouraging work from home options to reduce our employees' carbon footprint; a transit per diem that encourages employees to use public transit and rideshare during business travel vs. rental cars; migrating to solar energy in division offices; and integrating alternate fuel vehicles into fleets
• Charitable giving efforts that give back to non-profit organizations that share its commitment to diversity, wellness, and our youth, contributing more than $200,000 to organizations nationwide in 2022
• Corporate compliance efforts that include Safety Committees, URAC accreditation, and HITRUST certification

Click here to access MTM's ESG Charter. 

About MTM

MTM is the nation's most trusted and qualified partner for healthcare, transportation, and logistics solutions. Since 1995, MTM has managed NEMT for state and county governments, managed care organizations, health systems, and other programs involving transportation for the disabled, underserved, and elderly. Leveraging technology to streamline processes and improve the user experience for all stakeholders, MTM's wide spectrum of services help clients improve health outcomes, promote independence, reduce costs, and increase satisfaction. Every year, MTM removes community barriers for 15.4 million people by providing more than 20.75 million trips in 31 states and the District of Columbia. MTM is a privately held, woman-owned business enterprise.

Contact Information:
Ashley Wright
Senior Manager, Marketing
[email protected]


Press Release Service by Newswire.com

Original Source: MTM Releases Formal ESG Charter Reflecting Commitment to Social Responsibility